Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
Conditions: Anemia; Chronic Kidney Disease; Kidney DiseaseInterventions: Drug: Darbepoetin Alfa; Drug: PlaceboSponsor: AmgenTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2007 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials